Organ‐aware CBCT enhancement via dual path learning for prostate cancer treatment
Medical Physics · 2023
DOI: 10.1002/mp.16752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Physics, 2023. Verfasst von Xu Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science and Technology, Huaqiao University, Xiamen, China. Hauptthemen laut MEDLINE: Spiral Cone-Beam Computed Tomography, Prostatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Cone‐beam computed tomography (CBCT) plays a crucial role in the intensity modulated radiotherapy (IMRT) of prostate cancer. However, poor image contrast and fuzzy organ boundaries pose challenges to precise targeting for dose delivery and plan reoptimization for adaptive therapy.
Purpose
In this work, we aim to enhance pelvic CBCT images by translating them to high‐quality CT images with a particular focus on the anatomical structures important for radiotherapy.
Methods
We develop a novel dual‐path learning framework, covering both global and local information, for organ‐aware enhancement of the prostate, bladder and rectum. The global path learns coarse inter‐modality translation at the image level. The local path learns organ‐aware translation at the regional level. This dual‐path learning architecture can serve as a plug‐and‐play module adaptable to other medical image‐to‐image translation frameworks.
Results
We evaluated the performance of the proposed method both quantitatively and qualitatively. The training dataset consists of unpaired 40 CBCT and 40 CT scans, the validation dataset consists of 5 paired CBCT‐CT scans, and the testing dataset consists of 10 paired CBCT‐CT scans. The peak signal‐to‐noise ratio (PSNR) between enhanced CBCT and reference CT images is 27.22 ± 1.79, and the structural similarity (SSIM) between enhanced CBCT and the reference CT images is 0.71 ± 0.03. We also compared our method with state‐of‐the‐art image‐to‐image translation methods, where our method achieves the best performance. Moreover, the statistical analysis confirms that the improvements achieved by our method are statistically significant.
Conclusions
The proposed method demonstrates its superiority in enhancing pelvic CBCT images, especially at the organ level, compared to relevant methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Computer Science and Technology, Huaqiao University, Xiamen, China.
- Key Laboratory of Computer Vision and Machine Learning (Huaqiao University), Fujian Province University, Xiamen, China.
- Xiamen Key Laboratory of Computer Vision and Pattern Recognition, Huaqiao University, Xiamen, China.
- Department of Computer Science, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Biomedical Research Imaging Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- National Institutes of Health
Zitieren
APA
Chen, X., Pang, Y., Ahmad, S., Royce, T., Wang, A., Lian, J., & Yap, P. T. (2023). Organ‐aware CBCT enhancement via dual path learning for prostate cancer treatment. Medical Physics. https://doi.org/10.1002/mp.16752
Vancouver
Chen X, Pang Y, Ahmad S, Royce T, Wang A, Lian J, et al. Organ‐aware CBCT enhancement via dual path learning for prostate cancer treatment. Medical Physics. 2023. doi:10.1002/mp.16752
BibTeX
@article{Chen2023,
author = {Chen, Xu and Pang, Yunkui and Ahmad, Sahar and Royce, Trevor and Wang, Andrew and Lian, Jun and Yap, Pew-Thian},
title = {Organ‐aware CBCT enhancement via dual path learning for prostate cancer treatment},
journal = {Medical Physics},
year = {2023},
doi = {10.1002/mp.16752}
}
EUVIMED